Weight loss by overweight and obese people associated with reduced risk of colorectal adenoma

A new paper in JNCI Cancer Spectrum, published by Oxford University Press, indicates that overweight and obese people who lose weight may reduce their chances of later developing colorectal adenoma – a type of benign growth or polyp in the colon or rectum that could lead to colorectal cancer. Colorectal cancer is the third most common type of cancer and the third leading cause of death from cancer among men and women in the United States.

Over the past 30 years, obesity has increased in the United States and worldwide, leading to increased development of many chronic diseases. Obesity is a known risk factor for colorectal adenoma and colorectal cancer.

Doctors recommend weight loss for overweight and obese people commonly. Although weight loss is thought to have some beneficial health effects, whether losing weight can reduce the chance of developing colorectal adenoma has been an open question. Most studies have only investigated colorectal adenoma risk in relation to obesity or body mass index assessed at one time point, with fewer studies assessing the role of weight change.

Researchers here assessed weight change (including both weight gain and weight loss) over three periods of adulthood in relation to colorectal adenoma using self-reported weight data in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial. The trial enrolled 154,942 men and women in the United States ages 55 to 74 from 1993 to 2001 to evaluate the effectiveness of different screening approaches in preventing death from various cancers. This current study used data from participants in the screening arm of the trial, who received a colorectal cancer screening test at baseline and again 3 or 5 years later.

The investigators found that, compared to stable weight, weight loss in adulthood (defined as loss greater than or equal to 1.1 pounds per 5 years) was associated with a 46% reduced risk for colorectal adenoma. This was particularly true among adults who were initially overweight or obese. The investigators also reported that weight gain in adulthood was associated with an increased chance of adenoma, particularly for weight gain greater than 6.6 pounds over 5 years. Findings for weight loss and weight gain appeared stronger among men than women. The researchers believe that the findings suggest the importance of healthy weight maintenance throughout adulthood in preventing colorectal adenoma. Additionally, adults who are overweight or obese may be able to reduce their risk for developing colorectal adenoma by losing weight.

Our findings suggest that avoiding weight gain in adulthood may help lower someone's chance of developing a pre-cancerous growth called colorectal adenoma, which may in turn reduce the risk of developing colorectal cancer. Based on our findings, we would not recommend weight loss for all adults. But the results suggest that overweight and obese adults may benefit from weight loss."

Kathryn Hughes Barry, Study's Senior Author

Source:
Journal reference:

He, S., et al. (2022) Weight Change and Incident Distal Colorectal Adenoma Risk in the PLCO Cancer Screening Trial. JNCI Cancer Spectrum. doi.org/10.1093/jncics/pkab098.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Scientists discover key protein that helps cancer cells evade CAR T cell therapy